These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 20945494)

  • 1. Maximizing productivity of CHO cell-based fed-batch culture using chemically defined media conditions and typical manufacturing equipment.
    Huang YM; Hu W; Rustandi E; Chang K; Yusuf-Makagiansar H; Ryll T
    Biotechnol Prog; 2010; 26(5):1400-10. PubMed ID: 20945494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Process development for a recombinant Chinese hamster ovary (CHO) cell line utilizing a metal induced and amplified metallothionein expression system.
    Huang EP; Marquis CP; Gray PP
    Biotechnol Bioeng; 2004 Nov; 88(4):437-50. PubMed ID: 15459913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fed-batch bioreactor performance and cell line stability evaluation of the artificial chromosome expression technology expressing an IgG1 in Chinese hamster ovary cells.
    Combs RG; Yu E; Roe S; Piatchek MB; Jones HL; Mott J; Kennard ML; Goosney DL; Monteith D
    Biotechnol Prog; 2011; 27(1):201-8. PubMed ID: 21312367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single nutrient feed supports both chemically defined NS0 and CHO fed-batch processes: Improved productivity and lactate metabolism.
    Ma N; Ellet J; Okediadi C; Hermes P; McCormick E; Casnocha S
    Biotechnol Prog; 2009; 25(5):1353-63. PubMed ID: 19637321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein-free fed-batch culture of non-GS NS0 cell lines for production of recombinant antibodies.
    Burky JE; Wesson MC; Young A; Farnsworth S; Dionne B; Zhu Y; Hartman TE; Qu L; Zhou W; Sauer PW
    Biotechnol Bioeng; 2007 Feb; 96(2):281-93. PubMed ID: 16933323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conversion of a CHO cell culture process from perfusion to fed-batch technology without altering product quality.
    Meuwly F; Weber U; Ziegler T; Gervais A; Mastrangeli R; Crisci C; Rossi M; Bernard A; von Stockar U; Kadouri A
    J Biotechnol; 2006 May; 123(1):106-16. PubMed ID: 16324762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Batch, fed-batch, and microcarrier cultures with CHO cell lines in a pressure-cycle driven miniaturized bioreactor.
    Kim BJ; Zhao T; Young L; Zhou P; Shuler ML
    Biotechnol Bioeng; 2012 Jan; 109(1):137-45. PubMed ID: 21965160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Process parameter shifting: Part II. Biphasic cultivation-A tool for enhancing the volumetric productivity of batch processes using Epo-Fc expressing CHO cells.
    Trummer E; Fauland K; Seidinger S; Schriebl K; Lattenmayer C; Kunert R; Vorauer-Uhl K; Weik R; Borth N; Katinger H; Müller D
    Biotechnol Bioeng; 2006 Aug; 94(6):1045-52. PubMed ID: 16736532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bcl-x(L) mediates increased production of humanized monoclonal antibodies in Chinese hamster ovary cells.
    Chiang GG; Sisk WP
    Biotechnol Bioeng; 2005 Sep; 91(7):779-92. PubMed ID: 15986489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of a fed-batch process for TNFR-fc producing GS-CHO cells].
    Fan L; Zhao L; Sun Y; Kou T; Tan W
    Sheng Wu Gong Cheng Xue Bao; 2010 Feb; 26(2):216-22. PubMed ID: 20432941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of cultivation conditions in spin tubes for Chinese hamster ovary cells producing erythropoietin and the comparison of glycosylation patterns in different cultivation vessels.
    Strnad J; Brinc M; Spudić V; Jelnikar N; Mirnik L; Carman B; Kravanja Z
    Biotechnol Prog; 2010; 26(3):653-63. PubMed ID: 20544713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-end pH-controlled delivery of glucose effectively suppresses lactate accumulation in CHO fed-batch cultures.
    Gagnon M; Hiller G; Luan YT; Kittredge A; DeFelice J; Drapeau D
    Biotechnol Bioeng; 2011 Jun; 108(6):1328-37. PubMed ID: 21328318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase in efficiency of media utilization for recombinant protein production in Chinese hamster ovary culture through dilution.
    Thombre S; Gadgil M
    Biotechnol Appl Biochem; 2011; 58(1):25-31. PubMed ID: 21446956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel micro-bioreactor high throughput technology for cell culture process development: Reproducibility and scalability assessment of fed-batch CHO cultures.
    Amanullah A; Otero JM; Mikola M; Hsu A; Zhang J; Aunins J; Schreyer HB; Hope JA; Russo AP
    Biotechnol Bioeng; 2010 May; 106(1):57-67. PubMed ID: 20073088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a fed-batch culture process for enhanced production of recombinant human antithrombin by Chinese hamster ovary cells.
    Kuwae S; Ohda T; Tamashima H; Miki H; Kobayashi K
    J Biosci Bioeng; 2005 Nov; 100(5):502-10. PubMed ID: 16384788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced cell culture performance using inducible anti-apoptotic genes E1B-19K and Aven in the production of a monoclonal antibody with Chinese hamster ovary cells.
    Figueroa B; Ailor E; Osborne D; Hardwick JM; Reff M; Betenbaugh MJ
    Biotechnol Bioeng; 2007 Jul; 97(4):877-92. PubMed ID: 17099908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the intracellular effect of enhanced nutrient feeding toward high titer antibody production process.
    Yu M; Hu Z; Pacis E; Vijayasankaran N; Shen A; Li F
    Biotechnol Bioeng; 2011 May; 108(5):1078-88. PubMed ID: 21165902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CHO gene expression profiling in biopharmaceutical process analysis and design.
    Schaub J; Clemens C; Schorn P; Hildebrandt T; Rust W; Mennerich D; Kaufmann H; Schulz TW
    Biotechnol Bioeng; 2010 Feb; 105(2):431-8. PubMed ID: 19777598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of a production process in a membrane-aerated stirred tank and up to 1000-L airlift bioreactors using BHK-21 cells and chemically defined protein-free medium.
    Hesse F; Ebel M; Konisch N; Sterlinski R; Kessler W; Wagner R
    Biotechnol Prog; 2003; 19(3):833-43. PubMed ID: 12790647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of cell culture process changes on endogenous retrovirus expression.
    Brorson K; De Wit C; Hamilton E; Mustafa M; Swann PG; Kiss R; Taticek R; Polastri G; Stein KE; Xu Y
    Biotechnol Bioeng; 2002 Nov; 80(3):257-67. PubMed ID: 12226857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.